203 related articles for article (PubMed ID: 28939099)
41. The prognostic significance of p53 expression in gastric cancer: a meta-analysis.
Wei K; Jiang L; Wei Y; Wang Y; Qian X; Dai Q; Guan Q
J Cancer Res Clin Oncol; 2015 Apr; 141(4):735-48. PubMed ID: 25316440
[TBL] [Abstract][Full Text] [Related]
42. The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers.
Yu FY; Xu Q; Wu DD; Lau AT; Xu YM
PLoS One; 2016; 11(8):e0159801. PubMed ID: 27483432
[TBL] [Abstract][Full Text] [Related]
43. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor receptor-3 is a favorable prognostic factor in advanced gastric carcinoma.
Sung JY; Lee S; Kim YW; Park YK
Oncol Rep; 2008 Apr; 19(4):939-44. PubMed ID: 18357379
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
[TBL] [Abstract][Full Text] [Related]
46. Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature.
Wang S; Zheng G; Cheng B; Chen F; Wang Z; Chen Y; Wang Y; Xiong B
PLoS One; 2014; 9(6):e99259. PubMed ID: 24901848
[TBL] [Abstract][Full Text] [Related]
47. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
Hu H; Cai W; Zheng S; Ge W
Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
[TBL] [Abstract][Full Text] [Related]
48. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
49. Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis.
Liu JX; Wei ZY; Chen JS; Lu HC; Hao L; Li WJ
World J Surg Oncol; 2015 Jun; 13():207. PubMed ID: 26109060
[TBL] [Abstract][Full Text] [Related]
50. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.
Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
52. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Liang C; Zhang K; Ge H; Li W; Li G; Wu J
Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological and prognostic significance of octamer-binding transcription factor 4 in patients with gastric cancer: a systematic review and meta-analysis.
Wei Y; Liu H; Wang C; Zhang W; Wen X; Long H; Xu Z; Guo H; Liu Y; Wei D; Qiu C; Li G; Sun Z
Biomark Med; 2019 Feb; 13(3):219-234. PubMed ID: 30810340
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis.
Yin S; Li Z; Huang J; Miao Z; Zhang J; Lu C; Xu H; Xu H
Onco Targets Ther; 2017; 10():319-327. PubMed ID: 28138255
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Significance of ADAM17 for Gastric Cancer Survival: A Meta-Analysis.
Ni P; Yu M; Zhang R; He M; Wang H; Chen S; Duan G
Medicina (Kaunas); 2020 Jun; 56(7):. PubMed ID: 32610677
[No Abstract] [Full Text] [Related]
56. Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis.
Liang C; Xu Y; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():47-57. PubMed ID: 29317833
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis.
Liang C; Zhao J; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():3561-3571. PubMed ID: 29950861
[TBL] [Abstract][Full Text] [Related]
58. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes.
Kitadai Y; Kodama M; Cho S; Kuroda T; Ochiumi T; Kimura S; Tanaka S; Matsumura S; Yasui W; Chayama K
Int J Cancer; 2005 Jun; 115(3):388-92. PubMed ID: 15688374
[TBL] [Abstract][Full Text] [Related]
59. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z
BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological and prognostic significance of SOX9 expression in gastric cancer patients: A meta-analysis.
Wang Q; Chen H; Yang C; Liu Y; Li F; Zhang C
Medicine (Baltimore); 2022 Sep; 101(37):e30533. PubMed ID: 36123852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
